THE ROLE OF PHARMACISTS, NURSES, AND MEDICAL PRACTITIONER IN MEDICATION ADHERENCE AND PERSONALIZED MEDICINE
Main Article Content
Keywords
pharmacists, nurses, medication adherence, personalized medicine, drug management.
Abstract
This research examines the vital importance of pharmacists and nurses in promoting drug adherence and individualized care. Efficient teamwork and well-defined responsibilities are crucial for improving patient care and meeting their requirements. The absence of clearly defined roles in healthcare and medication optimization impedes interprofessional collaboration. This study intends to explore the roles of pharmacists and nurses in enhancing medication utilization and health outcomes. The research investigates the many roles carried out by nurses and the increasing tendency of broadening their area of practice, such as taking on advanced medical responsibilities in certain nations. The text emphasizes the significant differences in nurses' responsibilities in interprofessional pharmacological therapy and their impact on patient care in various nations. The research highlights the significance of medication management in promoting patient well-being and optimizing therapeutic results. The text covers important aspects of drug management, including minimizing adverse responses, enhancing prescription adherence, and conducting regular evaluation and monitoring of drugs. Nurses have a crucial role in medication management and adherence. They are crucial in improving patient outcomes by providing thorough care management, which include medication education, monitoring physiological conditions, and aiding in patient recovery and safety. Nurses must have a comprehensive grasp of safe medication delivery and adverse drug responses to quickly identify and address issues.
References
1. Wilson A, Palmer L, Levett-Jones T, Gilligan C, Outram S. Interprofessional collaborative practice for medication safety: Nursing, pharmacy, and medical graduates’ experiences and perspectives. J Interprof Care. 2016; 30(5):649–54. https://doi.org/10.1080/13561820. 2016.1191450 PMID: 27351385
2. Azhar S, Hassali M, Mohamed Ibrahim M, Saleem F, Siow Yen L. A survey evaluating nurses’ perception and expectations towards the role of pharmacist in Pakistan’s healthcare system. J Adv Nurs. 2012; 68(1):199–205. https://doi.org/10.1111/j.1365-2648.2011.05728.x PMID: 21658097
3. Ensing H, Stuijt C, van den BemtB, van Dooren A, Karapinar-C¸arkit F, Koster E, et al. Identifying the Optimal Role for Pharmacists in Care Transitions: A Systematic Review. J Manag Care Spec Pharm. 2015; 21(8):614–36. https://doi.org/10.18553/jmcp.2015.21.8.614 PMID: 26233535
4. Maier C, Aiken L. Task shifting from physicians to nurses in primary care in 39 countries: a cross-country comparative study. Eur J Public Health. 2016; 26(6):927–34. https://doi.org/10.1093/eurpub/ckw098 PMID:27485719
5. Borrott N, Kinney S, Newall F, Williams A, Cranswick N, WongI, et al. Medication communication between nurses and doctors for paediatric acute care: An ethnographic study. J Clin Nurs. 2017; 26 (13–14):1978–92. https://doi.org/10.1111/jocn.13606 PMID: 27706878
6. Manias E. Effects of interdisciplinary collaboration in hospitals on medication errors: an integrative review. Expert Opin Drug Saf. 2018; 17(3):259–75. https://doi.org/10.10 80/14740338.2018.1424830 PMID:29303376
7. Thoma J, Waite M. Experiences of nurse case managers within a central discharge planning role of collaboration between physicians, patients and other healthcare professionals: A sociocultural qualitative study. J Clin Nurs. 2018; 27(5–6):1198–208. https://doi.org/10. 1111/jocn.14166 PMID: 29148105
8. Allemann S, van Mil J, Botermann L, BergerK, Griese N, Hersberger K. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014; 36(3):544–55. https://doi.org/10.1007/s11096-0149933-x PMID:24748506
9. Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47(3):533–43. PMID: 2316538
10. Kijlstra N, Ridge K, Walser S. Pharmaceutical care: where dowestand—where should we go? Key concepts in pharmaceutical care, quality assessment of pharmaceutical care in Europe, sources of information: survey report. Strasbourg: European Directorate for the Quality of Medicines & HealthCare (EDQM),2009.
11. Keitel S. Pharmaceutical care–policies and practices for a safer, more responsible and cost-effective health system. Strasbourg: European Directorate for the Quality of Medicines & HealthCare (EDQM), 2012.
12. Choo J, Hutchinson A, Bucknall T. Nurses’ role in medication safety. J Nurs Manag.2010; 18(7):85361. https://doi.org/10.1111/j.1365-2834.2010.01164.x PMID: 20946221
13. De Baetselier E, Van Rompaey B, Batalha L M, Bergqvist M, Czarkowska-Paczek B, DeSantis A, et al. EUPRON: nurses’ practice in interprofessional pharmaceutical care in Europe. A cross-sectional survey in 17 countries. BMJ Open. 2020; 10(6):e036269. https://doi.org/10.1136/bmjopen-2019-036269 PMID:32499269
14. Council of Europe. Resolution CM/res(2020)3on the implementation of pharmaceutical care for the benefit of patients and health services. 2020. Retrieved from https://search.coe.int/cm/pages/result_ details.aspx?objectid=09000016809cdf26
15. Association of Registered Nursesof New found landand Labrador. Scopeof NursingPractice:definition, decision-making & delegation. 2006. Retrieved from https://www.crnnl.ca/sites/default/files/documents/ RD_Scope_of_Nursing_Practice_0.pdf
16. Leporini C, et al. Adherence to therapy and adverse drug reactions: Is there a link? Expert opinion on drug safety. 2014; 13(sup1):41-55.
17. Li W, et al. Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management. Therapeutics and clinical risk management. 2013;259-271.
18. Lovell MR, et al. Patient education, coaching, and self-management for cancer pain. Journal of Clinical Oncology; 2014.
19. Wittich CM, et al. Medication errors: an overview for clinicians. Mayo Clinic Proceedings Elsevier; 2014.
20. Pharmacy ACoC, et al. Improving care transitions: Current practice and future opportunities for pharmacists. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2012 32(11):e326-e337.
21. Montamat S C, Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly [J]. Clinics in geriatric medicine, 1992, 8(1): 143-158.
22. Hristoskova A, et al. Ontology- driven monitoring of patient’s vital signs enabling personalized medical detection and alert. Sensors. 2014;14(1):1598- 1628.
23. Organization WH. Promoting rational use of medicines: Core components, World Health Organization; 2002.
24. Dolu I, et al. Transitional ‘hospital to home’care of older patients: Healthcare professionals’ perspectives. Scandinavian Journal of Caring Sciences. 2021;35(3): 871-880.
25. Scullin C, et al. An innovative approach to integrated medicines management. Journal of Evaluation in Clinical Practice. 2007;13(5):781-788.
26. Li J-P O, et al. Digital technology, tele- medicine and artificial intelligence in ophthalmology: A global perspective. Progress in retinal and eye research. 2021; 82:100900.
27. Johansson P, et al. Patient satisfaction with nursing care in the context of health care: A literature study. Scandinavian Journal of Caring Sciences. 2002;16(4): 337-344.
28. Gogtay N, et al. The use and safety of non- allopathic Indian medicines. Drug safety. 2002;25: 1005-1019.
29. Mitchell P, et al. Core principles & values of effective team-based health care. NAM Perspectives; 2012.
30. Powell RE, Doty A, Casten RJ, Rovner BW, Rising KL. A qualitative analysis of interprofessional healthcare team members’ perceptions of patient barriers to healthcare engagement. BMC Health Serv Res. 2016;16(1). doi:10.1186/s12913-016-1751-5
31. Probst S, Allet L, Depeyre J, Colin S, Buehrer Skinner M. A targeted interprofessional educational intervention to address therapeutic adher- ence of venous leg ulcer persons (TIEIVLU): study protocol for a randomized controlled trial. Trials. 2019;20(1). doi:10.1186/s13063- 019-3333-4
32. Gordon C, Unni E, Montuoro J, Ogborn DB. Community pharmacist- led clinical services: physician’s understanding, perceptions and readiness to collaborate in a Midwestern state in the United States. Int J Pharm Pract. 2018;26(5):407–413. doi:10.1111/ijpp.12421
33. Zschoche JH, Nesbit S, Murtaza U, et al. Development and imple- mentation of procedures for outpatient naloxone prescribing at a large academic medical center. Am J Health Pharm. 2018;75 (22):1812–1820. doi:10.2146/ajhp170759
34. Cope R, Berkowitz L, Arcebido R, Yeh J-Y, Trustman N, Cha A. Evaluating the effects of an interdisciplinary practice model with pharmacist collaboration on HIV patient co-morbidities. AIDS Patient Care STDS. 2015;29(8):445–453. doi:10.1089/apc.2015.0018
35. Ulrich L-R, Pham T-NT, Gerlach FM, Erler A. Family health teams in Ontario: ideas for Germany from a Canadian primary care model. Gesundheitswesen. 2019;81(6):492–497. doi:10.1055/s-0043-111406
36. Chan B, Reeve E, Matthews S, et al. Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards. Br J Clin Pharmacol. 2017;83(6):1185–1196. doi:10.1111/bcp.13222
37. Turner K, Weinberger M, Renfro C, et al. The role of network ties to support implementation of a community pharmacy enhanced services network. Res Soc Adm Pharm. 2019;15(9):1118–1125. doi:10.1016/j. sapharm.2018.09.015
38. Higgins KL, Hauck FR, Tanabe K, Tingen J. Role of the ambulatory care clinical pharmacist in management of a refugee patient popula- tion at a university-based refugee healthcare clinic. J Immigr Minor Health. 2020;22(1):17–21. doi:10.1007/s10903-019-00879-5
39. Lelubre M, Clerc O, Grosjean M, et al. Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results. BMC Health Serv Res. 2018;18(1). doi:10.1186/s12913-018-3641-5
40. Swanoski MT, Little MM, St Hill CA, Ware KB, Chapman S, Lutfiyya MN. Potentially inappropriate medication prescribing in U.S. older adults with selected chronic conditions. Consult Pharm J Am Soc Consult Pharm. 2017;32(9):525–534. doi:10.4140/TCP. n.2017.525
41. Boylan P, Joseph T, Hale G, Moreau C, Seamon M, Jones R. Chronic obstructive pulmonary disease and heart failure self-management kits for outpatient transitions of care. Consult Pharm J Am Soc Consult Pharm. 2018;33(3):152–158. doi:10.4140/TCP.n.2018.152
42. Swallow V, Smith T, Webb NJA, et al. Distributed expertise: quali- tative study of a British network of multidisciplinary teams support- ing parents of children with chronic kidney disease. Child Care Health Dev. 2015;41(1):67–75. doi:10.1111/cch.12141
43. Rieck AM. Exploring the nature of power distance on general practi- tioner and community pharmacist relations in a chronic disease management context. J Interprof Care. 2014;28(5):440–446. doi:10.3109/13561820.2014.906390
44. Lalonde L, Goudreau J, Duhamel F, Be D, Le L. Priorities for action to improve cardiovascular preventive care of patients with multi- morbid conditions in primary care — a participatory action research project. Fam Pract. 2012;1–9. DOI:10.1093/fampra/cms021
45. Shaneyfelt TM, et al. Are guidelines following guidelines?: The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. Jama 1999;281 (20): 1900-1905.
46. Ma CS. Role of pharmacists in optimizing the use of anticancer drugs in the clinical setting. Integrated Pharmacy Research and Practice. 2014;11-24.
47. Hustoft M, Biringer E, Gjesdal S, Aßus J, Hetlevik Ø. Relational coordination in interprofessional teams and its effect on patient-reported benefit and continuity of care: a prospective cohort study from rehabilitation centres in Western Norway 11 Medical and Health Sciences 1117 Public Health and Health Ser. BMC Health Serv Res. 2018;18(1):1–9. doi:10.1186/s12913-018-3536-5
48. Reeves S, Xyrichis A, Zwarenstein M. Teamwork, collaboration, coordination, and networking: why we need to distinguish between different types of interprofessional practice. J Interprof Care. 2018;32(1):1–3. doi:10.1080/13561820.2017.1400150
49. Given BA, et al. Family support in advanced cancer. CA: A Cancer Journal for Clinicians 2001;51(4):213-231.
50. Kripalani S, et al. Promoting effective transitions of care at hospital discharge: A review of key issues for hospitalists. Journal of Hospital Medicine: An Official Publication of the Society of Hospital Medicine. 2007; 2(5):314-323.
51. Wager KA, et al. Health care information systems: a practical approach for health care management. John Wiley & Sons; 2021.
2. Azhar S, Hassali M, Mohamed Ibrahim M, Saleem F, Siow Yen L. A survey evaluating nurses’ perception and expectations towards the role of pharmacist in Pakistan’s healthcare system. J Adv Nurs. 2012; 68(1):199–205. https://doi.org/10.1111/j.1365-2648.2011.05728.x PMID: 21658097
3. Ensing H, Stuijt C, van den BemtB, van Dooren A, Karapinar-C¸arkit F, Koster E, et al. Identifying the Optimal Role for Pharmacists in Care Transitions: A Systematic Review. J Manag Care Spec Pharm. 2015; 21(8):614–36. https://doi.org/10.18553/jmcp.2015.21.8.614 PMID: 26233535
4. Maier C, Aiken L. Task shifting from physicians to nurses in primary care in 39 countries: a cross-country comparative study. Eur J Public Health. 2016; 26(6):927–34. https://doi.org/10.1093/eurpub/ckw098 PMID:27485719
5. Borrott N, Kinney S, Newall F, Williams A, Cranswick N, WongI, et al. Medication communication between nurses and doctors for paediatric acute care: An ethnographic study. J Clin Nurs. 2017; 26 (13–14):1978–92. https://doi.org/10.1111/jocn.13606 PMID: 27706878
6. Manias E. Effects of interdisciplinary collaboration in hospitals on medication errors: an integrative review. Expert Opin Drug Saf. 2018; 17(3):259–75. https://doi.org/10.10 80/14740338.2018.1424830 PMID:29303376
7. Thoma J, Waite M. Experiences of nurse case managers within a central discharge planning role of collaboration between physicians, patients and other healthcare professionals: A sociocultural qualitative study. J Clin Nurs. 2018; 27(5–6):1198–208. https://doi.org/10. 1111/jocn.14166 PMID: 29148105
8. Allemann S, van Mil J, Botermann L, BergerK, Griese N, Hersberger K. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014; 36(3):544–55. https://doi.org/10.1007/s11096-0149933-x PMID:24748506
9. Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47(3):533–43. PMID: 2316538
10. Kijlstra N, Ridge K, Walser S. Pharmaceutical care: where dowestand—where should we go? Key concepts in pharmaceutical care, quality assessment of pharmaceutical care in Europe, sources of information: survey report. Strasbourg: European Directorate for the Quality of Medicines & HealthCare (EDQM),2009.
11. Keitel S. Pharmaceutical care–policies and practices for a safer, more responsible and cost-effective health system. Strasbourg: European Directorate for the Quality of Medicines & HealthCare (EDQM), 2012.
12. Choo J, Hutchinson A, Bucknall T. Nurses’ role in medication safety. J Nurs Manag.2010; 18(7):85361. https://doi.org/10.1111/j.1365-2834.2010.01164.x PMID: 20946221
13. De Baetselier E, Van Rompaey B, Batalha L M, Bergqvist M, Czarkowska-Paczek B, DeSantis A, et al. EUPRON: nurses’ practice in interprofessional pharmaceutical care in Europe. A cross-sectional survey in 17 countries. BMJ Open. 2020; 10(6):e036269. https://doi.org/10.1136/bmjopen-2019-036269 PMID:32499269
14. Council of Europe. Resolution CM/res(2020)3on the implementation of pharmaceutical care for the benefit of patients and health services. 2020. Retrieved from https://search.coe.int/cm/pages/result_ details.aspx?objectid=09000016809cdf26
15. Association of Registered Nursesof New found landand Labrador. Scopeof NursingPractice:definition, decision-making & delegation. 2006. Retrieved from https://www.crnnl.ca/sites/default/files/documents/ RD_Scope_of_Nursing_Practice_0.pdf
16. Leporini C, et al. Adherence to therapy and adverse drug reactions: Is there a link? Expert opinion on drug safety. 2014; 13(sup1):41-55.
17. Li W, et al. Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management. Therapeutics and clinical risk management. 2013;259-271.
18. Lovell MR, et al. Patient education, coaching, and self-management for cancer pain. Journal of Clinical Oncology; 2014.
19. Wittich CM, et al. Medication errors: an overview for clinicians. Mayo Clinic Proceedings Elsevier; 2014.
20. Pharmacy ACoC, et al. Improving care transitions: Current practice and future opportunities for pharmacists. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2012 32(11):e326-e337.
21. Montamat S C, Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly [J]. Clinics in geriatric medicine, 1992, 8(1): 143-158.
22. Hristoskova A, et al. Ontology- driven monitoring of patient’s vital signs enabling personalized medical detection and alert. Sensors. 2014;14(1):1598- 1628.
23. Organization WH. Promoting rational use of medicines: Core components, World Health Organization; 2002.
24. Dolu I, et al. Transitional ‘hospital to home’care of older patients: Healthcare professionals’ perspectives. Scandinavian Journal of Caring Sciences. 2021;35(3): 871-880.
25. Scullin C, et al. An innovative approach to integrated medicines management. Journal of Evaluation in Clinical Practice. 2007;13(5):781-788.
26. Li J-P O, et al. Digital technology, tele- medicine and artificial intelligence in ophthalmology: A global perspective. Progress in retinal and eye research. 2021; 82:100900.
27. Johansson P, et al. Patient satisfaction with nursing care in the context of health care: A literature study. Scandinavian Journal of Caring Sciences. 2002;16(4): 337-344.
28. Gogtay N, et al. The use and safety of non- allopathic Indian medicines. Drug safety. 2002;25: 1005-1019.
29. Mitchell P, et al. Core principles & values of effective team-based health care. NAM Perspectives; 2012.
30. Powell RE, Doty A, Casten RJ, Rovner BW, Rising KL. A qualitative analysis of interprofessional healthcare team members’ perceptions of patient barriers to healthcare engagement. BMC Health Serv Res. 2016;16(1). doi:10.1186/s12913-016-1751-5
31. Probst S, Allet L, Depeyre J, Colin S, Buehrer Skinner M. A targeted interprofessional educational intervention to address therapeutic adher- ence of venous leg ulcer persons (TIEIVLU): study protocol for a randomized controlled trial. Trials. 2019;20(1). doi:10.1186/s13063- 019-3333-4
32. Gordon C, Unni E, Montuoro J, Ogborn DB. Community pharmacist- led clinical services: physician’s understanding, perceptions and readiness to collaborate in a Midwestern state in the United States. Int J Pharm Pract. 2018;26(5):407–413. doi:10.1111/ijpp.12421
33. Zschoche JH, Nesbit S, Murtaza U, et al. Development and imple- mentation of procedures for outpatient naloxone prescribing at a large academic medical center. Am J Health Pharm. 2018;75 (22):1812–1820. doi:10.2146/ajhp170759
34. Cope R, Berkowitz L, Arcebido R, Yeh J-Y, Trustman N, Cha A. Evaluating the effects of an interdisciplinary practice model with pharmacist collaboration on HIV patient co-morbidities. AIDS Patient Care STDS. 2015;29(8):445–453. doi:10.1089/apc.2015.0018
35. Ulrich L-R, Pham T-NT, Gerlach FM, Erler A. Family health teams in Ontario: ideas for Germany from a Canadian primary care model. Gesundheitswesen. 2019;81(6):492–497. doi:10.1055/s-0043-111406
36. Chan B, Reeve E, Matthews S, et al. Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards. Br J Clin Pharmacol. 2017;83(6):1185–1196. doi:10.1111/bcp.13222
37. Turner K, Weinberger M, Renfro C, et al. The role of network ties to support implementation of a community pharmacy enhanced services network. Res Soc Adm Pharm. 2019;15(9):1118–1125. doi:10.1016/j. sapharm.2018.09.015
38. Higgins KL, Hauck FR, Tanabe K, Tingen J. Role of the ambulatory care clinical pharmacist in management of a refugee patient popula- tion at a university-based refugee healthcare clinic. J Immigr Minor Health. 2020;22(1):17–21. doi:10.1007/s10903-019-00879-5
39. Lelubre M, Clerc O, Grosjean M, et al. Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results. BMC Health Serv Res. 2018;18(1). doi:10.1186/s12913-018-3641-5
40. Swanoski MT, Little MM, St Hill CA, Ware KB, Chapman S, Lutfiyya MN. Potentially inappropriate medication prescribing in U.S. older adults with selected chronic conditions. Consult Pharm J Am Soc Consult Pharm. 2017;32(9):525–534. doi:10.4140/TCP. n.2017.525
41. Boylan P, Joseph T, Hale G, Moreau C, Seamon M, Jones R. Chronic obstructive pulmonary disease and heart failure self-management kits for outpatient transitions of care. Consult Pharm J Am Soc Consult Pharm. 2018;33(3):152–158. doi:10.4140/TCP.n.2018.152
42. Swallow V, Smith T, Webb NJA, et al. Distributed expertise: quali- tative study of a British network of multidisciplinary teams support- ing parents of children with chronic kidney disease. Child Care Health Dev. 2015;41(1):67–75. doi:10.1111/cch.12141
43. Rieck AM. Exploring the nature of power distance on general practi- tioner and community pharmacist relations in a chronic disease management context. J Interprof Care. 2014;28(5):440–446. doi:10.3109/13561820.2014.906390
44. Lalonde L, Goudreau J, Duhamel F, Be D, Le L. Priorities for action to improve cardiovascular preventive care of patients with multi- morbid conditions in primary care — a participatory action research project. Fam Pract. 2012;1–9. DOI:10.1093/fampra/cms021
45. Shaneyfelt TM, et al. Are guidelines following guidelines?: The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. Jama 1999;281 (20): 1900-1905.
46. Ma CS. Role of pharmacists in optimizing the use of anticancer drugs in the clinical setting. Integrated Pharmacy Research and Practice. 2014;11-24.
47. Hustoft M, Biringer E, Gjesdal S, Aßus J, Hetlevik Ø. Relational coordination in interprofessional teams and its effect on patient-reported benefit and continuity of care: a prospective cohort study from rehabilitation centres in Western Norway 11 Medical and Health Sciences 1117 Public Health and Health Ser. BMC Health Serv Res. 2018;18(1):1–9. doi:10.1186/s12913-018-3536-5
48. Reeves S, Xyrichis A, Zwarenstein M. Teamwork, collaboration, coordination, and networking: why we need to distinguish between different types of interprofessional practice. J Interprof Care. 2018;32(1):1–3. doi:10.1080/13561820.2017.1400150
49. Given BA, et al. Family support in advanced cancer. CA: A Cancer Journal for Clinicians 2001;51(4):213-231.
50. Kripalani S, et al. Promoting effective transitions of care at hospital discharge: A review of key issues for hospitalists. Journal of Hospital Medicine: An Official Publication of the Society of Hospital Medicine. 2007; 2(5):314-323.
51. Wager KA, et al. Health care information systems: a practical approach for health care management. John Wiley & Sons; 2021.
Article Sidebar
Published
Nov 22, 2022
Article Details
How to Cite
Ahlam juwaybir Alanazi, Fahad hassan saeed alqahtani, Ahmed Nasser Altamimi, Abdullah Batel Alshammari, Mohammed Nasser Aldossari, Satam saleh alshakrah, mamdouh khalf Almutairi, Abdullah Ali Abdulrahman Alahmari, Abdulaziz Abdo Agili, Ibrahim Ismail Hamami, & Afaf Mohammed Hendi Hendi. (2022). THE ROLE OF PHARMACISTS, NURSES, AND MEDICAL PRACTITIONER IN MEDICATION ADHERENCE AND PERSONALIZED MEDICINE. Journal of Population Therapeutics and Clinical Pharmacology, 29(04), 2047-2054. https://doi.org/10.53555/jptcp.v29i04.5080
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Ahlam juwaybir Alanazi
Ksa ,Ministry of Health
Fahad hassan saeed alqahtani
Ksa ,Ministry of Health
Ahmed Nasser Altamimi
Ksa ,Ministry of Health
Abdullah Batel Alshammari
Ksa ,Ministry of Health
Mohammed Nasser Aldossari
Ksa ,Ministry of Health
Satam saleh alshakrah
Ksa ,Ministry of Health
mamdouh khalf Almutairi
Ksa ,Ministry of Health
Abdullah Ali Abdulrahman Alahmari
Ksa ,Ministry of Health
Abdulaziz Abdo Agili
Ksa ,Ministry of Health
Ibrahim Ismail Hamami
Ksa ,Ministry of Health
Afaf Mohammed Hendi Hendi
Ksa ,Ministry of Health
How to Cite
Ahlam juwaybir Alanazi, Fahad hassan saeed alqahtani, Ahmed Nasser Altamimi, Abdullah Batel Alshammari, Mohammed Nasser Aldossari, Satam saleh alshakrah, mamdouh khalf Almutairi, Abdullah Ali Abdulrahman Alahmari, Abdulaziz Abdo Agili, Ibrahim Ismail Hamami, & Afaf Mohammed Hendi Hendi. (2022). THE ROLE OF PHARMACISTS, NURSES, AND MEDICAL PRACTITIONER IN MEDICATION ADHERENCE AND PERSONALIZED MEDICINE. Journal of Population Therapeutics and Clinical Pharmacology, 29(04), 2047-2054. https://doi.org/10.53555/jptcp.v29i04.5080